In the field of oncology, recently three biological markers have been added to conventional breast cancer risk models to identify women at a higher risk of breast cancer. Increasing awareness about early testing and growing base of target population are the key factors contributing toward dominance On the other hand, lung cancer is expected to witness fastest growth over the forecast period.
United States Leads the Cancer Biomarkers Market The United States cancer biomarker market held the largest market share in in the North America region due to the presence of high-quality healthcare system, and the high rate of prevalence of cancer.
Biomarkers are used in single or in combination to identify health or disease of individual. Thus, the substantial increase in the incidence and mortality rate of liver cancer in the country is expected to boost the growth of the cancer biomarkers market, shortly. Global Biomarkers Market A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures.
The main driving factors for biomarkers market are increase in number of low cost for conducting clinical trials in developing countries. The testing cost of biomarkers is high. Furthermore, the report incorporates market attractiveness analysis by geography that depicts the most attractive and significant region in the global market in The use of biomarkers in diagnostic process is increasing rapidly due to its more accurate results.
Such an increase in this deadly ailment is also due a surge in habits such as smoking and drinking, as well as exposure to high amounts of particulate matter and pollution. Diagnostic biomarkers for early diagnosis enable doctors on deciding better treatment alternatives leading to successful recovery in lesser time.
For instance, American Cancer Society stated that inthere will be an estimated 1, new cancer cases diagnosed. Research activities are particularly focused on the development of diagnostics biomarkers for cancer.
Cancer biomarkers are used during diagnosis of cancer, especially during diagnostic and prognostic stages of cancer. North America and Asia Pacific markets for cancer biomarkers to witness high growth in the next few years. Increasing incidence of cancer across the globe is a major factor driving growth of the global cancer biomarkers market.
This applies particularly to the cancer field with the advent of novel cancer biomarkers. Cancer biomarkers are used in three ways that help diagnose conditions as in the case of identifying early stage cancers, to forecast how aggressive a condition is, as in the case of determining a patient's ability to fare in the absence of treatment, and to predict how well a patient will respond to treatment.
The market is likely to register a promising It plans to expand to include other tumor types over this period. Among these, the lung cancer segment is predicted to lead the market in the coming few years, owing to the rising prevalence of lung cancer, especially in emerging economies.
Inaroundcases of breast cancer have been reported in the U. For example, a new protein array technology developed by researchers from the Arizona State University is expected to detect antibodies targeting proteins in Human Papillomavirus HPV subtypes that are highly associated with cancer.
Genetic biomarkers owing to their extensive usage, high-reliability rate, and easier analysis held a significant market share. However, the Asia Pacific region owing to increasing prevalence of cancer, beneficial environment for clinical trials, and increasing government funding for supporting drug development programs is anticipated to witness lucrative CAGR over the forecast period.
This lack of data has been a limiting factor for many years, but the trend is changing. Research and development activities hold the potential to define the future outlook of the global biomarkers market.
Report Summary Cancer Biomarkers Market Cancer biomarkers are a biological molecule secreted either by tumors or from tissues in response to cancer, which then later used to measure and evaluate the cancer growth processes in the body.
Growing prevalence of malignancies coupled with increasing focus on development of targeted therapies is a major factor affirming positive growth of this market.
Different varieties of biomarkers are used currently for various applications. Application-wise, the market can be bifurcated into diagnostic development, disease risk assessment, drug discovery and development, personalized medicine, and other applications such as ecotoxicology, DNA fingerprinting, and forensics.
Market share analysis among the market players is analyzed to signify percentage share of the major players operating in the cancer biomarkers market.
Furthermore, the report incorporates market attractiveness analysis by geography that depicts the most attractive and significant region in.
The growing usage of biomarkers in medical areas such as cancer treatment and research will propel the future growth of the global biomarkers market. Biomarkers are extensively used to detect diseases such as neurological disorders, immunological disorders, cancer, cardiovascular disorders, and thesanfranista.comon: State Tower, 90 State Street, SuiteAlbany, Increasing incidence of cancer across the globe is a major factor driving growth of the global cancer biomarkers market.
For instance, American Cancer Society stated that inthere will be an estimated 1, new cancer cases diagnosed.4/4. Market share analysis among the market players is analyzed to signify percentage share of the major players operating in the cancer biomarkers market.
Furthermore, the report incorporates market attractiveness analysis by geography that depicts the most attractive and significant region in the global market Location: State Tower, 90 State Street, SuiteAlbany, Industry Insights.
The global cancer biomarker market size was valued at USD billion in the year and is estimated to reach a value of USD billion bygrowing with CAGR of %.
The global cancer biomarkers market has been categorized into disease indication into blood cancer, stomach cancer, liver cancer, lung cancer, ovarian cancer, melanoma, colorectal cancer, breast cancer, and prostate cancer.Global cancer biomarkers market size share